Table 3.
Animal model | MSCs source | Other biological adjuvant | Scaffold material | Experimental time (weeks) | Spinal fusion level |
Experimental design | Main outcome | Reference |
---|---|---|---|---|---|---|---|---|
Pig | ADSCs from inguinal subcutaneous tissue | None | DBM | 8 and 12 weeks | L2–L6 |
Group 1: one cage was left and three filled with freeze dried irradiated cancellous pig bone graft Group 2: freeze dried irradiated cancellous pig bone graft Group 3: cancellous bone autograft Group 4: bone graft with 3D osteogenic differentiated ADSCs |
µ-CT scan, microradiography, and histology/histomorphometry demonstrated a significant increase in bone content in group 4 | [50] |
| ||||||||
Sheep | Expanded and osteogenic induced BMSCs from iliac crest (5-6 × 107) |
Fibrin | TCP/HA | 12 weeks | L1–L6 |
Group 1: HA with MSCs Group 2: TCP/HA with MSCs Group 3: autograft |
(i) Radiography, manual palpation, histological analysis, and SEM analyses revealed demonstrated better bone formation in group 2 compared to group 1 (ii) Histomorphometry detected 55.8% of new bone in group 3, followed by group 2 (42.7%) and group 1 (10.7%) |
[51] |
| ||||||||
Sheep | Allogenic sheep mesenchymal precursor cells (MPCs) from BM from iliac crest | None | HA/TCP | 16–36 weeks | L2–L5 |
Group 1: autograft Group 2: HA/TCP Group 3: HA/TCP with MPCs (25 × 106) Group 4: HA/TCP with MPCs (75 × 106) Group 5: HA/TCP with MPCs (225 × 106) |
Computed tomography, high-resolution radiography, biomechanical testing, organ pathology, bone histopathology, and bone histomorphometry showed that allogeneic mesenchymal precursor cells produced fusion efficacy similar to that achieved using iliac crest autograft |
[52] |
| ||||||||
Sheep | Allogenic MPCs from BM from sheep iliac crest | None | HA/TCP | 16 weeks | L4-L5 |
Group 1: autograft Group 2: HA/TCP with MPCs (2.5 × 106) Group 3: HA/TCP with MPCs (6.5 × 106) Group 4: HA/TCP with MPCs (12.5 × 106) |
(i) Manual palpation of the fusion site indicated solid fusion in more than 75% of MPC-treated group and 65% of group 1 (ii) Computed tomography and histomorphometry analyses showed all animals in the MPCs groups and group 1 fusion masses were present at 16 weeks |
[53] |
| ||||||||
Sheep | Expanded and osteoinduced BM from iliac crest | None | HA | 6 months | L4-L5 |
Group 1: autograft Group 2: allograft Group 3: HA Group 4: HA with MSCs. |
(i) By CT scan and histology lumbar fusion were higher for groups 1 and 2 (70%) than for group 3 (22%) and group 4 (35%) (ii) New bone formation was higher for groups 1 and 2 (iii) Group 4 had a better fusion rate than group 3, but the histology showed no significant differences between them in terms of quantity of bone formation |
[54] |
| ||||||||
Sheep | BM concentrate (1.5 × 106 in 0.2 mL) | None | Natural bone collagen scaffold (NBCS) from human organic bone particles | 6 and 10 weeks | L3-L4 and L4-L5 |
Group 1: autograft Group 2: NBCS Group 3: BMCs Group 4: NBCS with BMCs |
(i) Solid spinal fusion was achieved in all six segments (6/6) in group 4 at 10 weeks, compared with 4/8 segments in group 1, 2/8 segments in group 2, and 3/6 segments in group 3 (ii) The biomechanical stiffness of fusion masses and bone volume at the fusion site were higher in group 4 (p < 0.05) (iii) At 10 weeks, the radiographic score reached was significantly higher in group 4 than in groups 1, 2 and 3 (iv) Histological findings revealed that group 4 induced new bone formation integrated well with host bone tissue |
[55] |
| ||||||||
Ewes | Allogenic MPCs (5 × 106) or allogenic amnion epithelial stem cells (5 × 106 AECs) |
None | Fidji interbody cage made from polyetheretherketone and HA/TCP |
3 months | C3-C4 |
Group 1: cage packed with autograft Group 2: cage packed with HA/TCP Group 3: cage packed with HA/TCP and MPCs Group 4: cage packed with HA/TCP and AECs Group 5: controls |
(i) Significant fusion mass was detected in group 3 compared to that in groups 1, 2, or 4 (ii) CT scan at 3 months revealed that 5/6 animals in group 3 (83%) had continuous bony bridging compared with 0/ 5 of group 4 and 1/6 of group 1 and 2/6 of group 2 (p < 0.01) |
[56] |
| ||||||||
Ewes | Allogeneic MPCs (5 × 106 or 10 × 106) |
None | Fidji interbody cage made from polyetheretherketone and HA/TCP |
3 months | C3-C4 anterior cervical discectomy and fusion with a interbody cage |
Group 1: cage packed with autograft Group 2: cage packed with HA/TCP Group 3: cage packed with HA/TCP and 5 × 106 MPCs Group 4: cage packed with HA/TCP and 10 × 106 MPCs Group 5: controls |
(i) No significant differences were found between groups 3 and 4 (ii) CT scan showed that 9/12 (75%) MPC-treated animals had continuous bony bridging compared with 1/6 of group 1 and 2/6 of group 2 (p < 0.019 and p < 0.044, resp.) (iii) By quantitative CT, density of new bone in MPC-treated animals was 121% higher than in group 2 (p < 0.017) and 128% higher than in group 1 (p < 0.0001) |
[57] |
| ||||||||
Pig | BMSCs (10 × 106) |
rhBMP-2 (0.6 mg) |
Bioresorbable scaffolds made from medical grade poly (Σ-caprolactone)-20% tricalcium phosphate (mPCL/TCP) |
9 months | L2-L3 and L4-L5 |
Group 1: mPCL/TCP with rhBMP-2 Group 2: mPCL/TCP with BMSCs Group 3: mPCL/TCP Group 4: autograft |
(i) The mean radiographic scores were 3.0, 1.7, 1.0, and 1.8 for groups 1 to 4, respectively (ii) The bone volume fraction of group 1 was twofold higher than group 2 (iii) Histology, µ-CT, and biomechanical evaluation showed solid and comparable fusion between groups 1 and 4 (iv) Group 2 showed inferior quality of fusion when compared with groups 1 and 4 while group 3 showed no fusion even at 9 months |
[58] |
| ||||||||
Ovine | Autogenous whole BM or BM concentrate | None | TCP | 6 months | L4-L5 |
Group 1: autograft Group 2: TCP with BM concentrate Group 3: TCP with whole bone marrow/ Group 4: TCP . |
(i) At 6 months, 33% of group 2 and 25% of the group 1 sites were fused, compared with 8% of group 3 and 0% of group 4 (ii) Histology of fused samples showed denser bone formation in group 2 than in group 1 sites |
[59] |